Clinical Trial Update: A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in Belgium [Phase 1]

View source ↗

Summary

A Phase 1 safety and pharmacokinetic study of a dapivirine and maraviroc gel for HIV infections in Belgium has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dapivirine (dapivirine)
• Maraviroc (maraviroc)

Snippet

Sponsor: International Partnership for Microbicides, Inc. | Conditions: HIV Infections | Phase 1 | Status: WITHDRAWN